Skip to content

N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide

C20H20N6O3 — CID 169074343

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACN-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide
SMILESCc1cccc(-n2nccc2-c2ccc3ncc(C(=O)NC(CO)CO)n3c2)n1
InChIInChI=1S/C20H20N6O3/c1-13-3-2-4-19(23-13)26-16(7-8-22-26)14-5-6-18-21-9-17(25(18)10-14)20(29)24-15(11-27)12-28/h2-10,15,27-28H,11-12H2,1H3,(H,24,29)
InChIKeyAHJMPZUBDJWIIJ-UHFFFAOYSA-N
MW392.42 g/mol
LogP0.97
Rot. Bonds6

About N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide

N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide (PubChem CID 169074343) has the molecular formula C20H20N6O3 and a molecular weight of 392.42 g/mol. Its IUPAC name is N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide.

Molecular Properties

Compound NameN-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide
PubChem CID169074343
Molecular FormulaC20H20N6O3
Molecular Weight392.42 g/mol
Exact Mass392.16
IUPAC NameN-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide
SMILESCc1cccc(-n2nccc2-c2ccc3ncc(C(=O)NC(CO)CO)n3c2)n1
InChIInChI=1S/C20H20N6O3/c1-13-3-2-4-19(23-13)26-16(7-8-22-26)14-5-6-18-21-9-17(25(18)10-14)20(29)24-15(11-27)12-28/h2-10,15,27-28H,11-12H2,1H3,(H,24,29)
InChIKeyAHJMPZUBDJWIIJ-UHFFFAOYSA-N
XLogP0.97
TPSA117.57 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500392.42
LogP ≤ 50.97
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide?
The IUPAC name of N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide (CID 169074343) is N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide.
What is the SMILES notation for N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide?
The canonical SMILES for N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide is Cc1cccc(-n2nccc2-c2ccc3ncc(C(=O)NC(CO)CO)n3c2)n1.
What is the InChIKey of N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide?
The InChIKey is AHJMPZUBDJWIIJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H20N6O3/c1-13-3-2-4-19(23-13)26-16(7-8-22-26)14-5-6-18-21-9-17(25(18)10-14)20(29)24-15(11-27)12-28/h2-10,15,27-28H,11-12H2,1H3,(H,24,29).
What are the key properties of N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide?
N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide has a molecular weight of 392.42 g/mol, XLogP of 0.97, 6 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1,3-dihydroxypropan-2-yl)-6-[2-(6-methyl-2-pyridinyl)pyrazol-3-yl]imidazo[1,2-a]pyridine-3-carboxamide is sourced from PubChem (CID 169074343), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.